Skip to Main Content
Boston University
  • Bostonia
  • BU Today
  • The Brink
  • University Publications

    • Bostonia
    • BU Today
    • The Brink
  • School & College Publications

    • The Record
Other Publications
BU Today
  • Sections
News, Research, Community

Student spotlight: an essay by Jennifer Ziegenfuss

Neuromarketing: Evolution of advertising or unethical use of medical technology?

August 10, 2006
Twitter Facebook
Jennifer Ziegenfuss (CAS '05)

Throughout August, BU Today will publish pieces of student scholarship and creative work. Jennifer Ziegenfuss (CAS ’05) majored in Biology with a specialization in Neuroscience. During her time as a BU undergrad, she spent two years working in the lab of Dr. Mary Erskine through the UROP program.  She is currently a Ph.D. student at the University of Massachusetts Medical School, in the lab of Marc Freeman.

Research at Emory University in Atlanta, Georgia, initiated by Dr. Clinton Kilts has unearthed some interesting results stemming from MRI studies in cognitive neuroscience. The scientists conducting the study discovered a biological cue to what may be driving personal preference. When the study volunteers saw a picture presented to them while undergoing an MRI brain scan they liked, their brains showed increased activity in the medial prefrontal cortex (AJC). When the brain’s medial prefrontal cortex lights up, is can be discerned that the image displayed is strongly liked by the subject (Fig 1). The medial prefrontal cortex is an area in the brain that has been associated with preference and sense of self. Advertisers say that the quality which makes us loyal customers is a brand that reflects our self-image, not by just taste, size, or color alone (AJC).

The Emory study, funded through Atlanta consulting firm BrightHouse and by a Fortune 500 client (either Coca-Cola, Delta Air Lines, Georgia-Pacific, or Met-Life), has created controversy over the emerging field of, "neuromarketing". Neuromarketing is a commercial offshoot of the growing field of the medical and scientific research known as cognitive neuroscience. In cognitive neuroscience, researchers use high technological brain-imaging devices such as MRI and fMRI scanners to uncover biological explanations for mental illness, neurogenitive diseases, chemical imbalances, and why we love, hate, envy, or cooperate (AJC). Marketers now want to use such tools as MRI scanners to find out which product images cause response in the medial prefrontal cortex in order to bolster their product sales (Cranston).

Neuromarketing has stirred up ethical questions surrounding the validity of using such devices for marketing purposes. Is it a manipulative way of selling unneeded products to unsuspecting people, and ultimately distorting the marketplace relationship? Or, is it just a new, more scientific and evolved form of consumer interest research?

Critics of neuromarketing say that MRI research, which allows better understanding of depression, addiction, and schizophrenia, should not be used by companies such as Ford, McDonalds, or Budweiser to unconsciously entice people to buy more of their product. Gary Ruskin, executive director of Commercial Alert has stated that, "It’s wrong to use medical technology for marketing and not for healing…we have epidemics of irresponsible spending, dept, obesity, diabetes, alcoholism, gambling, and smoking – all tied into marketing, and any increase in the effectiveness of advertising can be devastating to the public" (AJC). Proponents say in contrast that consumers’ responses have always been carefully observed as a means of gauging the effectiveness of targeting the audience. Focus groups are a type of social science and have been use for a long time, and neuromarketing techniques do not deviate much from this type of method. They state that the technology used for cognitive neuroscience and neuromarketing does not exclusively belong to medicine, rather, is an application of physics and biology and is essentially neutral. Although, with any type of technology, it may be used or abused as critics point out (Cranston).

Vulnerability of the public is a major bioethical concern. Proponents of neuromarketing say that people are not and will not be vulnerable to the power of suggestion, and if the consumer really does not want to buy something, they won’t. Contrary to this statement, it has been indicated that people may actually be quite vulnerable to the power of suggestion, especially with the media. Studies have shown that in countries which do not receive television and western media, there is a considerable lack of anorexia and bulimia in the population (Irving, NAMI). On a social level, much of society is driven by fads and what seems "hot" in the marketplace. By suggesting the notion of being happy and self-actualized with buying a certain product, could this be a mode of unconscious suggestion that could possibly lead to more social problems? Although this question is valid, as advertisers say, the marketplace relationship has never been a level playing field. Neuromarketing is just another method to try and trick the buyer into purchasing, and that only the most naïve could believe that the seller ever gives the buyer all necessary information. There should be the assumption, proponents say, that the sellers are spinning their products, and that the general public has enough self responsibility to say that they aren’t going to buy it (Cranston).

Ethical use of the MRI technology is also an issue. Currently, it takes thousands of dollars to run a single MRI scan, not to mention a great deal more to purchase the machine itself. Universities and hospitals use funds and grants to procure MRI scanners and to run experiments. Comparatively, monies from large corporations such as Coca-Cola or Microsoft are in much higher quantity than scientific research funds. This may tip the scales for future MRI research. More studies may be conducted for advertising purposes rather than for medical uses, which helps humanity and facilitates science and should be the top priority.

Whenever new applications for technologies emerge, as with neuromarketing, the bioethical question needs to be addressed whether the application is detrimental toward individuals and society as a whole. Questions of whether neuromarketing is just a benign method to help companies better understand customers’ true desires while giving customers the power to influence companies should be addressed as well as determining whether this method is a way of unconsciously suggesting the purchase of an otherwise unwanted item. The issue surrounding what should and should not be considered facilitative research for the benefit of humanity also needs to be addressed as to whether marketing MRI studies are justified or would seize intensity away from medical research.

 

BIBLIOGRAPHY
Cranston, Robert. "Neuromarketing: Unethical Advertising?" The Center for Bioethics and Human Dignity. 13, Feburary 2004.
Irving, L.M. and Neumark-Sztainer, D. (2002) “Integrating the prevention of eating disorders and obesity: Feasible or futile?” Preventive Medicine 34, 299-309.
National Alliance for the Mentally Ill. NAMI HelpLine fact sheet: Anorexia nervosa.
Wahlberg, David. "Advertisers Probe Brains, Raise Fears." The Atlanta Journal-Constitution. 2 February 2004.
  

Explore Related Topics:

  • Literature
  • Research
  • Share this story

Share

Student spotlight: an essay by Jennifer Ziegenfuss

Share

  • Twitter
  • Facebook
  • Reddit
  • LinkedIn
  • Email

Latest from BU Today

  • University News

    New BUPD Deputy Chief Brings Community-Centered Policing to the Forefront

  • New Appointment

    Prominent Women’s Health Researcher and Academic Leader Named Dean of BU Chobanian & Avedisian School of Medicine

  • Transportation

    MBTA Green Line B Branch Service to be Suspended Weekend of Sept 19-20 and September 26 to October 4

  • Things-to-do

    This Weekend @ BU: September 17 to 20

  • Varsity Sports

    BU Women’s Soccer Gears Up for Another Deep Playoff Run

  • Climate Change

    Sustainability Festivals on Medical and Charles River Campuses

  • University News

    Warren Towers’ Tower A Reopens to Students

  • University News

    Boston University Honors Four Junior Faculty With Prestigious Career Development Professorships

  • Class of 2030

    After Struggling to Support Himself in High School, Freshman Ryan Sim Is Ready to Chart His Own Course

  • New Appointment

    New University Librarian Aims to Create the Library of the Future, With the Community’s Help

  • 25th Anniversary of 9/11

    Mitchell Zuckoff Wrote Boston Globe Stories about 9/11

  • 25th Anniversary of 9/11

    September 11 – 25 Years Later, BU Experts Discuss

  • Things-to-do

    This Weekend @ BU: September 10 to 13

  • Varsity Sports

    BU Men’s Soccer to Host Army West Point in Patriot League Home Opener

  • Class of 2030

    A Snapshot of BU’s Class of 2030

  • Internship

    BU Launchpad Connects Rising Sophomores with Valuable Summer Internships

  • Study Abroad

    BU Study Abroad Expo

  • Students

    Eight Boston Experiences Every BU First-Year Should Try

  • Students

    Where to Eat at BU When You’re Hungry

  • Scholarships

    Boston University’s 2026 Menino Scholars and Community Leaders Scholars Arrive Ready to Change Their World

Section navigation

  • Sections
  • Must Reads
  • Videos
  • Series
  • Close ups
  • Archives
  • About + Contact
Get Our Email

Explore Our Publications

Bostonia

Boston University’s Alumni Magazine

BU Today

News, Research, Community

The Brink

Pioneering Research from Boston University

  • Twitter
  • Facebook
  • Youtube
  • LinkedIn
  • Instagram
  • Weibo
  • TikTok
© Boston University. All rights reserved. www.bu.edu
© 2026 Trustees of Boston UniversityPrivacy StatementAccessibility
Boston University
Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, age, national origin, ethnicity, shared ancestry and ethnic characteristics, physical or mental disability, sexual orientation, gender identity and/or expression, genetic information, pregnancy or pregnancy-related condition, military service, marital, parental, veteran status, or any other legally protected status in any and all educational programs or activities operated by Boston University. Retaliation is also prohibited. Please refer questions or concerns about Title IX, discrimination based on any other status protected by law or BU policy, or retaliation to Boston University’s Executive Director of Equal Opportunity/Title IX Coordinator, at titleix@bu.edu or (617) 358-1796. Read Boston University’s full Notice of Nondiscrimination.
Search
Boston University Masterplate
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Student spotlight: an essay by Jennifer Ziegenfuss
0
share this